CLVS
Clovis Oncology, Inc.
CLVS
CLVS
Delisted
CLVS was delisted on the 20th of December, 2022.
165 hedge funds and large institutions have $953M invested in Clovis Oncology, Inc. in 2018 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 61 increasing their positions, 54 reducing their positions, and 54 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
42% less capital invested
Capital invested by funds: $1.63B → $953M (-$677M)
50% less first-time investments, than exits
New positions opened: 27 | Existing positions closed: 54
Holders
165
Holding in Top 10
4
Calls
$57.6M
Puts
$32.9M
Top Buyers
| 1 | +$61.1M | |
| 2 | +$41M | |
| 3 | +$18.9M | |
| 4 |
SC
Samlyn Capital
New York
|
+$18.1M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$18M |
Top Sellers
| 1 | -$56.6M | |
| 2 | -$51.7M | |
| 3 | -$44.5M | |
| 4 |
PC
PointState Capital
New York
|
-$36M |
| 5 |
ACA
Avoro Capital Advisors
New York
|
-$33.7M |